Abstract
Aim
Assessing metastatic mesorectal nodal involvement is a challenge in rectal cancer, especially in the post chemoradiation setting. We aim to assess the accuracy of MRI for nodal restaging and the validity of SAR criteria (≥ 5 mm size being metastatic).
Materials and methods
This was an IRB-approved retrospective study of 166 patients with locally advanced rectal cancers, operated after neoadjuvant treatment. Two dedicated oncoradiologists reviewed the 166 post-chemoradiation presurgical MRIs in consensus. Nodal size and morphology (shape, margins, and signal intensity) were noted. The most accurate cut-off for size for predicting positive pN status was determined using the Youden index.
Results
MRI understaged 30/166 (18%) and overstaged 40/166 (24%) patients using the SAR criteria. The most accurate cut-off for node size was 5.5 mm, with a sensitivity of 75%, specificity of 60.2%, PPV of 40.7%, NPV of 86.9% (95% CI:78–92.5%), accuracy of 64.2%, and area under the curve (AUC) 0.657 (95% CI—0.524–0.79). Morphological characteristics were not significant to determine involvement, with positive nodes including 42% of round and 31% of oval nodes, 40% of heterogeneous and 45% of homogeneous nodes, and 31% irregularly marginated and 46% nodes with regular margins being positive on pathology. MRI was accurate in predicting pathology for mucinous nodes in 9/29 (31%) cases. Seven cases which were yN2 on MRI and yN0 on pathology demonstrated mucinous changes on MRI and had acellular mucin on histopathology.
Conclusions
MRI has good negative predictive value, poor positive predictive value and moderate accuracy in nodal restaging. The cut-off of 5.5 mm demonstrated in our study is close to the SAR cut-off of 5 mm in the post-treatment setting. MRI accuracy is lower in patients with mucinous nodes.
Similar content being viewed by others
References
Beets-Tan, R. G., Lambregts, D. M., Maas, M., Bipat, S., Barbaro, B., Caseiro-Alves, F (2013). Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. European radiology, 23(9), 2522–2531. https://doi.org/10.1007/s00330-013-2864-4.
de Wilt JH, Vermaas M, Ferenschild FT, Verhoef C (2007). Management of locally advanced primary and recurrent rectal cancer. Clinics in Colon and Rectal Surgery. Aug;20(3):255–263. https://doi.org/10.1055/s-2007-984870.
Arnoletti, J. P., & Bland, K. I. (2006). Neoadjuvant and adjuvant therapy for rectal cancer. Surgical oncology clinics of North America, 15(1), 147–157. https://doi.org/10.1016/j.soc.2005.08.001.
Taylor, F. G., Quirke, P., Heald, R. J., Moran, B., Blomqvist, L., Swift, I. et al & MERCURY study group (2011). Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg, 253(4), 711–719. https://doi.org/10.1097/SLA.0b013e31820b8d52.
Zhang, M. R., Xie, T. H., Chi, J. L., Li, Y., Yang, L., Yu, Y. Y., Sun, X. F., & Zhou, Z. G. (2016). Prognostic role of the lymph node ratio in node positive colorectal cancer: a meta-analysis. Oncotarget, 7(45), 72898–72907. https://doi.org/10.18632/oncotarget.12131.
Madbouly, K. M., Abbas, K. S., & Hussein, A. M. (2014). Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. American journal of surgery, 207(6), 824–831. https://doi.org/10.1016/j.amjsurg.2013.07.022.
Watanabe, T., Tsurita, G., Muto, T., Sawada, T., Sunouchi, K., Higuchi, Y et al (2002). Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery, 132(1), 27–33. https://doi.org/10.1067/msy.2002.125357
Nagawa, H., Muto, T., Sunouchi, K., Higuchi, Y., Tsurita, G., Watanabe, T., & Sawada, T. (2001). Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Diseases of the colon and rectum, 44(9), 1274–1280. https://doi.org/10.1007/BF02234784.
Komuta K, Okudaira S, Haraguchi M, Furui J, Kanematsu T (2001). Identification of extracapsular invasion of the metastatic lymph nodes as a useful prognostic sign in patients with resectable colorectal cancer. Dis Colon Rectum; 44:1838-44. https://doi.org/10.1007/s10120-008-0473-8
Ueno, H., Mochizuki, H., & Tamakuma, S. (1998). Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Diseases of the colon and rectum, 41(1), 55–61. https://doi.org/10.1007/BF02236896
Al-Sukhni, E., Milot, L., Fruitman, M., Beyene, J., Victor, J. C., Schmocker, S. et al (2012). Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Annals of surgical oncology, 19(7), 2212–2223. https://doi.org/10.1245/s10434-011-2210-5
Lahaye, M. J., Beets, G. L., Engelen, S. M., Kessels, A. G., de Bruïne, A. P., Kwee, H. W et al (2009). Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology, 252(1), 81–91. https://doi.org/10.1148/radiol.2521081364
Suppiah, A., Hunter, I. A., Cowley, J., Garimella, V., Cast, J., Hartley, J. E., et al (2009). Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland, 11(3), 249–253. https://doi.org/10.1111/j.1463-1318.2008.01593.x
Nahas, S. C., Nahas, C., Cama, G. M., de Azambuja, R. L., Horvat, N., Marques, C. et al (2019). Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer. Abdominal radiology (New York), 44(11), 3632–3640. https://doi.org/10.1007/s00261-019-01894-8
Gollub, M. J., Arya, S., Beets-Tan, R. G., dePrisco, G., Gonen, M., Jhaveri, K. et al (2018). Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017. Abdominal radiology (New York), 43(11), 2893–2902. https://doi.org/10.1007/s00261-018-1642-9
Edge SB, Byrd DR, Compton CC (2010). AJCC cancer staging handbook: from the AJCC cancer staging manual, 7th ed. New York, NY: Springer, 2010:718
Koh, D. M., Brown, G., Temple, L., Blake, H., Raja, A., Toomey, et al (2005) Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. European radiology, 15(8), 1650–1657. https://doi.org/10.1007/s00330-005-2751-8
Beets-Tan, R., Lambregts, D., Maas, M., Bipat, S., Barbaro, B., Curvo-Semedo, et al. (2018). Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. European radiology, 28(4), 1465–1475. https://doi.org/10.1007/s00330-017-5026-2
Heijnen, L. A., Maas, M., Beets-Tan, R. G., Berkhof, M., Lambregts, D. M., Nelemans, P. J et al. (2016). Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging? International journal of colorectal disease, 31(6), 1157–1162. https://doi.org/10.1007/s00384-016-2576-8
Kulkarni, T., Gollins, S., Maw, A., Hobson, P., Byrne, R., & Widdowson, D. (2008). Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland, 10(5), 479–489. https://doi.org/10.1111/j.1463-1318.2007.01451.x
Maretto, I., Pomerri, F., Pucciarelli, S., Mescoli, C., Belluco, E., Burzi, S., et al (2007). The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Annals of surgical oncology, 14(2), 455–461. https://doi.org/10.1245/s10434-006-9269-4
Kuo, L. J., Chern, M. C., Tsou, M. H., Liu, M. C., Jian, J. J., Chen, C. M. et al (2005). Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Diseases of the colon and rectum, 48(1), 23–28. https://doi.org/10.1007/s10350-004-0787-5
Chen, C. C., Lee, R. C., Lin, J. K., Wang, L. W., & Yang, S. H. (2005). How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Diseases of the colon and rectum, 48(4), 722–728. https://doi.org/10.1007/s10350-004-0851-1
Cho, Y. B., Chun, H. K., Kim, M. J., Choi, J. Y., Park, C. M., Kim, B. T. et al (2009). Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer. World journal of surgery, 33(12), 2688–2694. https://doi.org/10.1007/s00268-009-0248-3
Larsen, S. G., Wiig, J. N., Emblemsvaag, H. L., Grøholt, K. K., Hole, K. H., Bentsen, A. et al (2009). Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland, 11(7), 759–767. https://doi.org/10.1111/j.1463-1318.2008.01649.x
van den Broek, J. J., van der Wolf, F. S., Lahaye, M. J., Heijnen, L. A., Meischl, C., Heitbrink, M. A. et al (2017). Accuracy of MRI in Restaging Locally Advanced Rectal Cancer After Preoperative Chemoradiation. Diseases of the colon and rectum, 60(3), 274–283. https://doi.org/10.1097/DCR.0000000000000743
Lambregts, D. M., Maas, M., Riedl, R. G., Bakers, F. C., Verwoerd, J. L., Kessels, A. G et al (2011). Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study. European radiology, 21(2), 265–273. https://doi.org/10.1007/s00330-010-1937-x
Barbaro, B., Fiorucci, C., Tebala, C., Valentini, V., Gambacorta, M. A., Vecchio, F. M., Rizzo, G., Coco, C., Crucitti, A., Ratto, C., & Bonomo, L. (2009). Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology, 250(3), 730–739. https://doi.org/10.1148/radiol.2503080310
Seo, N., Kim, H., Cho, M. S., & Lim, J. S. (2019). Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences. Korean journal of radiology, 20(7), 1003–1018. https://doi.org/10.3348/kjr.2018.0611
Shia, J., McManus, M., Guillem, J. G., Leibold, T., Zhou, Q., Tang, L. H. et al (2011). Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. The American journal of surgical pathology, 35(1), 127–134. https://doi.org/10.1097/PAS.0b013e318200cf78
Napoletano, M., Mazzucca, D., Prosperi, E., Aisa, M. C., Lupattelli, M., Aristei, C., & Scialpi, M. (2019). Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy. Abdominal radiology (New York), 44(11), 3664–3673. https://doi.org/10.1007/s00261-019-02012-4
Krdzalic J, Maas M, Gollub MJ, Beets-Tan RGH (2019). Guidelines for MR imaging in rectal cancer: Europe versus United States. Abdominal Radiology (New York;44(11):3498–3507. https://doi.org/10.1007/s00261-019-02251-5.
van Heeswijk MM, Lambregts DM, Palm WM et al (2017) DWI for assessment of rectal cancer nodes after chemoradiotherapy: is the absence of nodes at DWI proof of a negative nodal status? AJR Am J Roentgenol 208:W79–W84
Ryu KH, Kim SH, Yoon JH et al (2016) Diffusion-weighted imaging for evaluating lymph node eradication after neoadjuvant chemoradiation therapy in locally advanced rectal cancer. Acta Radiol 57:133–141
Lambregts, D., Boellaard, T. N., & Beets-Tan, R. (2019). Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review. Insights into imaging, 10(1), 15. https://doi.org/10.1186/s13244-019-0706-x
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pangarkar, S., Mistry, K., Choudhari, A. et al. Accuracy of MRI for nodal restaging in rectal cancer: a retrospective study of 166 cases. Abdom Radiol 46, 498–505 (2021). https://doi.org/10.1007/s00261-020-02708-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-020-02708-y